English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Robert Hadley | Jun 23, 2017

Study explores eye contact avoidance by those with autism

+ Community
Erianne Leatherman | Jun 22, 2017

Chemotherapy can affect breast cancer patients’ gait and balance

+ Regulatory
Robert Hadley | Jun 22, 2017

Phase 3 trial of Pfizer’s prostate cancer drug could yield results two years early

+ Community
Carrie Bradon | Jun 22, 2017

Anthem leaving Wisconsin, Indiana health insurance marketplaces

+ Regulatory
Michael McGrady | Jun 22, 2017

FDA chief wants to speed up approvals for digital health tech

+ Technology/Innovation
Robert Hadley | Jun 21, 2017

Clinical trial deems AstraZeneca’s Lynparza better for mutation-caused breast cancer than chemotherapy

+ Regulatory
Ruth de Jauregui | Jun 21, 2017

Health care marketplace forecast brings call for more than just a fix

+ Technology/Innovation
Ruth de Jauregui | Jun 21, 2017

Medivizor to help LLS Community network supply health infomation to blood cancer patients

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 381
  • 382
  • 383
  • 384
  • 385
  • 386
  • 387
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily